Trademark: 79326559
Status Date
Tuesday, February 21, 2023
Registration Number
6982504
Registration Date
Tuesday, February 21, 2023
Filing Date
Wednesday, September 22, 2021
Published for Opposition
Tuesday, December 6, 2022
41 Educational services, namely, providing training in the field of medical and pharmaceutical products; organization and conducting of seminars, conferences, congresses, symposiums and training workshops in the field of medical and pharmaceutical products; online publication of books and journals in the field of medical and pharmaceutical products in electronic form, being publishing services; practical training in the field of medicine and pharmaceutical products; publication of texts other than advertising texts in the field of medicine and pharmaceutical products
5 Pharmaceutical preparations, namely, recombinant therapeutics for the treatment of HIV/AIDS; biological preparations for medical use, namely, recombinant therapeutics for the treatment of HIV/AIDS; antiviral preparations, namely, recombinant therapeutics being pharmaceutical preparations in the nature of antivirals; pharmaceutical products for the treatment of HIV/AIDS; chemical, analysis and diagnostic reagents for medical research and for medical and veterinary use in diagnostics; diagnosis preparations for medical purposes, namely, medical diagnostic reagents; diagnostic testing materials for medical use, namely, diagnostic kits comprised of medical diagnostic recombinant reagents and assays for detecting diseases
44 Monitoring of patients, namely, monitoring of medical data for medical diagnosis and treatment; advice in the field of beauty care; psychological assistance for patients; providing medical and health information about medical disorders; providing medical and health information about infection control; medical services for psychological counseling; patient support services in the nature of medical services relating to the treatment of medical disorders; medical services; providing health information; information and advisory services relating to pharmaceutical products, namely, medical and pharmaceutical consultation; online and in-person information and advisory services relating to the aforesaid
42 Pharmaceutical research and development; medical research in the field of recombinant therapeutics; clinical research services in the field of pharmaceuticals, namely, recombinant therapeutics; laboratory research services relating to pharmaceuticals; research and development services relating to new pharmaceutical products; laboratory materials analysis services being medical and scientific laboratory services; chemical analysis; scientific laboratory services; laboratory testing services, namely, medical and scientific laboratory services; medical research laboratory services; research and development services relating to pharmaceutical substances; technical consultancy in the pharmaceutical sector, namely, consulting services in the field of pharmaceutical research and development; online and in-person information and advisory services relating to the aforesaid
The wording "ALBAJUNA" has no meaning in a foreign language.
Jun 12, 2023
Final Decision Transaction Processed By Ib
May 24, 2023
Final Disposition Notice Sent To Ib
May 24, 2023
Final Disposition Processed
May 21, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 21, 2023
Notice Of Registration Confirmation Emailed
Feb 21, 2023
Registered-Principal Register
Dec 12, 2022
Notification Processed By Ib
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 23, 2022
Notification Of Possible Opposition Sent To Ib
Nov 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 2, 2022
Approved For Pub - Principal Register
Nov 2, 2022
Examiner's Amendment Entered
Nov 2, 2022
Notification Of Examiners Amendment E-Mailed
Nov 2, 2022
Examiners Amendment E-Mailed
Nov 2, 2022
Examiners Amendment -Written
Nov 2, 2022
Previous Allowance Count Withdrawn
Sep 20, 2022
Withdrawn From Pub - Og Review Query
Sep 6, 2022
Approved For Pub - Principal Register
Sep 6, 2022
Examiner's Amendment Entered
Sep 6, 2022
Notification Of Examiners Amendment E-Mailed
Sep 6, 2022
Examiners Amendment E-Mailed
Sep 6, 2022
Examiners Amendment -Written
Aug 26, 2022
Teas/Email Correspondence Entered
Aug 25, 2022
Correspondence Received In Law Office
Aug 25, 2022
Teas Response To Office Action Received
Jul 26, 2022
Refusal Processed By Ib
Jul 1, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 1, 2022
Refusal Processed By Mpu
Jun 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 28, 2022
Non-Final Action Written
Jun 24, 2022
Assigned To Examiner
Mar 15, 2022
Correction From The Ib Examined, No Action Is Needed
Jan 9, 2022
Correction Transaction Received From Ib
Dec 3, 2021
Application Filing Receipt Mailed
Nov 29, 2021
New Application Office Supplied Data Entered
Nov 25, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
